Picard Medical is trading 12.56% lower at $13.51, with no verified company-specific announcement or catalyst explaining the October 20 decline.
- Recent reporting also described the preceding sharp swings as lacking a clear catalyst.
- Healthcare ETF XLV advanced about 1% in premarket trading, making sector-wide weakness an unlikely explanation; available evidence does not establish a direct broader-market cause.